Abbott Laboratories
Abbott Laboratories (ABT) Option Chain
Abbott Laboratories trades at $103.00, down 0.84%, with an IV Rank of 54.76%. This is average versus the past year, and the company carries a market cap of $178,390M in the Medical Devices industry. On the Nov 27, 2026 chain, the at the money $103.00 strike shows calls at $1.40 / $2.15 and puts at $0.75 / $1.75, both carrying about $1.51 of extrinsic value. The call has a 49.99% probability of expiring out of the money, and the put has 50.01%. Volume is heaviest on the $103.00 calls, at 182 contracts, and the $105.00 puts, at 38, as of Nov 20, 2026.
Read more
Tracking the ABT option chain helps you see every strike and expiry on Abbott Laboratories in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABT options activity at a glance. Use our scanner to monitor the ABT option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABT stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ABT options are being actively traded, and where they are not.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 30.73 | 0 | 0 | 1.35 | 2.00 | 2.60 | 4.10 | 101.00 | -1.94 | 0.50 | 1.15 | 0.00 | 0.83 | 30 | 9 | 69.27 |
| 40.10 | 16 | 1 | 1.63 | 1.00 | 1.95 | 3.30 | 102.00 | -0.97 | 0.75 | 1.35 | 0.00 | 1.05 | 36 | 21 | 59.90 |
| 49.99 | 11 | 182 | 1.78 | 0.00 | 1.40 | 2.15 | 103.00 | 0.00 | 0.75 | 1.75 | 0.00 | 1.25 | 7 | 39 | 50.01 |
| 59.79 | 37 | 82 | 1.08 | 0.00 | 0.75 | 1.40 | 104.00 | +0.97 | 1.35 | 2.50 | 1.00 | 0.93 | 0 | 14 | 40.21 |
| 68.92 | 55 | 14 | 0.88 | 0.00 | 0.60 | 1.15 | 105.00 | +1.94 | 1.75 | 4.50 | 2.00 | 1.13 | 38 | 121 | 31.08 |
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV Rank54.76% Moderate
- Market cap (M$)178,390
- 52 weeks high-20.68%
- 52 weeks low25.66%
- Analyst recommendationBuy
1.58 - Target price$120.21
16.71% above the current stock price - Dividend—
- Payout ratio64.54%
- Earnings date2027-01-28
- P/E38.03
- Future P/E17.37
- EPS (ttm)2.71
- EPS growth next 5 years8.08%
As of Nov 20, 2026